(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ANXA6 mRNA] CTD PMID:31150632 (1->4)-beta-D-glucan multiple interactions ISO RGD:733719 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ANXA6 mRNA CTD PMID:36331819 1,2-dimethylhydrazine increases expression ISO RGD:733719 6480464 1, 2-Dimethylhydrazine results in increased expression of ANXA6 mRNA CTD PMID:22206623 17alpha-ethynylestradiol multiple interactions ISO RGD:733719 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ANXA6 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:733719 6480464 Ethinyl Estradiol results in increased expression of ANXA6 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:733718 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of ANXA6 mRNA CTD PMID:30165855 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:733719 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ANXA6 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of ANXA6 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ANXA6 mRNA CTD PMID:26232522 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:733719 6480464 Tetrachlorodibenzodioxin affects the expression of ANXA6 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:733719 6480464 Tetrachlorodibenzodioxin results in increased expression of ANXA6 mRNA CTD PMID:19770486 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of ANXA6 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of ANXA6 mRNA CTD PMID:21346803 2-amino-14,16-dimethyloctadecan-3-ol increases expression ISO RGD:733718 6480464 2-amino-14, 16-dimethyloctadecan-3-ol results in increased expression of ANXA6 protein CTD PMID:32044396 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:733719 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ANXA6 mRNA CTD PMID:16054899 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:733718 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ANXA6 mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane increases expression ISO RGD:733719 6480464 4, 4'-diaminodiphenylmethane results in increased expression of ANXA6 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression ISO RGD:733719 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of ANXA6 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol increases expression ISO RGD:733718 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of ANXA6 protein CTD PMID:34186270 4-hydroxyphenyl retinamide decreases expression ISO RGD:733719 6480464 Fenretinide results in decreased expression of ANXA6 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine multiple interactions ISO RGD:733718 6480464 [Decitabine co-treated with Vorinostat] affects the expression of ANXA6 mRNA CTD PMID:17330099 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of ANXA6 mRNA CTD PMID:25825206 aflatoxin B1 decreases expression ISO RGD:733719 6480464 Aflatoxin B1 results in decreased expression of ANXA6 mRNA CTD PMID:19770486 aflatoxin B1 increases methylation ISO RGD:733718 6480464 Aflatoxin B1 results in increased methylation of ANXA6 exon CTD PMID:30157460 aflatoxin B1 decreases expression ISO RGD:733718 6480464 Aflatoxin B1 results in decreased expression of ANXA6 mRNA CTD PMID:22100608 , PMID:27153756 all-trans-retinoic acid multiple interactions ISO RGD:733719 6480464 [bisphenol A co-treated with Tretinoin] results in decreased expression of ANXA6 mRNA, [bisphenol F co-treated with Tretinoin] results in decreased expression of ANXA6 mRNA CTD PMID:30951980 allethrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ANXA6 protein CTD PMID:34896426 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of ANXA6 mRNA CTD PMID:16483693 arsenite(3-) decreases expression ISO RGD:733718 6480464 arsenite results in decreased expression of ANXA6 mRNA CTD PMID:23974009 arsenite(3-) increases methylation ISO RGD:733718 6480464 arsenite results in increased methylation of ANXA6 promoter CTD PMID:23974009 benzatropine decreases expression ISO RGD:733718 6480464 Benztropine results in decreased expression of ANXA6 protein CTD PMID:34122009 benzo[a]pyrene decreases expression ISO RGD:733719 6480464 Benzo(a)pyrene results in decreased expression of ANXA6 mRNA CTD PMID:19770486 , PMID:20713471 benzo[a]pyrene decreases methylation ISO RGD:733719 6480464 Benzo(a)pyrene results in decreased methylation of ANXA6 exon, Benzo(a)pyrene results in decreased methylation of ANXA6 intron CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:733718 6480464 Benzo(a)pyrene results in increased methylation of ANXA6 5' UTR CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:733718 6480464 Benzo(a)pyrene results in decreased expression of ANXA6 mRNA CTD PMID:20106945 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ANXA6 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:733718 6480464 bisphenol A results in decreased expression of ANXA6 protein CTD PMID:31675489 more ... bisphenol A multiple interactions ISO RGD:733719 6480464 [bisphenol A co-treated with Tretinoin] results in decreased expression of ANXA6 mRNA CTD PMID:30951980 bisphenol A affects expression ISO RGD:733718 6480464 bisphenol A affects the expression of ANXA6 mRNA CTD PMID:30903817 bisphenol A increases expression ISO RGD:733719 6480464 bisphenol A results in increased expression of ANXA6 mRNA, bisphenol A results in increased expression of ANXA6 protein CTD PMID:28279065 , PMID:30951980 bisphenol A multiple interactions ISO RGD:733718 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ANXA6 mRNA CTD PMID:28628672 Bisphenol B increases expression ISO RGD:733718 6480464 bisphenol B results in increased expression of ANXA6 protein CTD PMID:34186270 bisphenol F multiple interactions ISO RGD:733719 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of ANXA6 mRNA CTD PMID:30951980 bisphenol F increases expression ISO RGD:733718 6480464 bisphenol F results in increased expression of ANXA6 protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:733719 6480464 bisphenol F results in increased expression of ANXA6 mRNA CTD PMID:30951980 bleomycin A2 decreases expression EXP 6480464 Bleomycin results in decreased expression of ANXA6 protein CTD PMID:25933445 butanal increases expression ISO RGD:733718 6480464 butyraldehyde results in increased expression of ANXA6 mRNA CTD PMID:26079696 C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of ANXA6 mRNA CTD PMID:19167457 carbon nanotube decreases expression ISO RGD:733719 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 chloroprene decreases expression ISO RGD:733719 6480464 Chloroprene results in decreased expression of ANXA6 mRNA CTD PMID:23125180 cisplatin increases expression ISO RGD:733718 6480464 Cisplatin results in increased expression of ANXA6 mRNA CTD PMID:27594783 clozapine decreases expression ISO RGD:733718 6480464 Clozapine results in decreased expression of ANXA6 protein CTD PMID:34122009 copper atom multiple interactions ISO RGD:733719 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ANXA6 mRNA CTD PMID:15467011 copper(0) multiple interactions ISO RGD:733719 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ANXA6 mRNA CTD PMID:15467011 copper(II) sulfate decreases expression ISO RGD:733718 6480464 Copper Sulfate results in decreased expression of ANXA6 mRNA CTD PMID:19549813 cyclosporin A decreases expression ISO RGD:733718 6480464 Cyclosporine results in decreased expression of ANXA6 mRNA CTD PMID:25562108 cyhalothrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ANXA6 protein CTD PMID:34896426 cylindrospermopsin decreases expression ISO RGD:733718 6480464 cylindrospermopsin results in decreased expression of ANXA6 mRNA CTD PMID:24921660 cypermethrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ANXA6 protein CTD PMID:34896426 cytarabine decreases expression ISO RGD:733718 6480464 Cytarabine results in decreased expression of ANXA6 mRNA CTD PMID:21198554 dexamethasone multiple interactions ISO RGD:733719 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ANXA6 mRNA CTD PMID:16054899 dexamethasone multiple interactions ISO RGD:733718 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ANXA6 mRNA CTD PMID:28628672 dexamethasone increases expression ISO RGD:733718 6480464 Dexamethasone results in increased expression of ANXA6 mRNA CTD PMID:25047013 diuron increases expression EXP 6480464 Diuron results in increased expression of ANXA6 mRNA CTD PMID:21551480 diuron decreases expression ISO RGD:733718 6480464 Diuron results in decreased expression of ANXA6 mRNA CTD PMID:35967413 dorsomorphin multiple interactions ISO RGD:733718 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA6 mRNA CTD PMID:27188386 doxorubicin increases expression ISO RGD:733718 6480464 Doxorubicin results in increased expression of ANXA6 mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of ANXA6 mRNA CTD PMID:29391264 fenthion increases expression ISO RGD:733719 6480464 Fenthion results in increased expression of ANXA6 mRNA CTD PMID:34813904 fenvalerate multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ANXA6 protein CTD PMID:34896426 flavonoids increases expression EXP 6480464 Flavonoids results in increased expression of ANXA6 mRNA CTD PMID:18035473 genistein increases expression ISO RGD:733719 6480464 Genistein results in increased expression of ANXA6 mRNA CTD PMID:32186404 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of ANXA6 mRNA CTD PMID:22061828 griseofulvin increases expression ISO RGD:733719 6480464 Griseofulvin results in increased expression of ANXA6 mRNA CTD PMID:12735108 heparin increases expression EXP 6480464 Heparin results in increased expression of ANXA6 protein CTD PMID:17488504 indometacin multiple interactions ISO RGD:733718 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ANXA6 mRNA CTD PMID:28628672 inulin multiple interactions ISO RGD:733719 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ANXA6 mRNA CTD PMID:36331819 irinotecan increases expression ISO RGD:733718 6480464 Irinotecan metabolite results in increased expression of ANXA6 mRNA, Irinotecan results in increased expression of ANXA6 mRNA CTD PMID:15956246 isoflavones multiple interactions EXP 6480464 [ENNG co-treated with Isoflavones] results in increased expression of ANXA6 protein CTD PMID:22248470 ivermectin decreases expression ISO RGD:733718 6480464 Ivermectin results in decreased expression of ANXA6 protein CTD PMID:32959892 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of ANXA6 mRNA CTD PMID:24136188 lidocaine increases expression EXP 6480464 Lidocaine results in increased expression of ANXA6 mRNA, Lidocaine results in increased expression of ANXA6 protein CTD PMID:27018092 methidathion increases expression ISO RGD:733719 6480464 methidathion results in increased expression of ANXA6 mRNA CTD PMID:34813904 methyl methanesulfonate decreases expression ISO RGD:733718 6480464 Methyl Methanesulfonate results in decreased expression of ANXA6 mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO RGD:733718 6480464 methylmercuric chloride results in decreased expression of ANXA6 mRNA CTD PMID:23179753 , PMID:27188386 morphine decreases expression EXP 6480464 Morphine results in decreased expression of ANXA6 protein CTD PMID:23056601 N-methyl-4-phenylpyridinium increases expression ISO RGD:733719 6480464 1-Methyl-4-phenylpyridinium results in increased expression of ANXA6 protein CTD PMID:26558463 N-methylformamide decreases expression ISO RGD:733719 6480464 methylformamide analog results in decreased expression of ANXA6 mRNA, methylformamide results in decreased expression of ANXA6 mRNA CTD PMID:17040096 N-nitrosomorpholine affects expression EXP 6480464 N-nitrosomorpholine affects the expression of ANXA6 protein CTD PMID:19716841 ozone multiple interactions ISO RGD:733719 6480464 [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of ANXA6 mRNA CTD PMID:27106289 paracetamol decreases expression ISO RGD:733718 6480464 Acetaminophen results in decreased expression of ANXA6 mRNA CTD PMID:29067470 pentanal increases expression ISO RGD:733718 6480464 pentanal results in increased expression of ANXA6 mRNA CTD PMID:26079696 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:733719 6480464 perfluorooctane sulfonic acid results in decreased expression of ANXA6 protein CTD PMID:26178269 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:733719 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ANXA6 mRNA, [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ANXA6 mRNA CTD PMID:36331819 phenobarbital affects expression ISO RGD:733719 6480464 Phenobarbital affects the expression of ANXA6 mRNA CTD PMID:23091169 phenobarbital increases expression ISO RGD:733718 6480464 Phenobarbital results in increased expression of ANXA6 protein CTD PMID:35881160 propanal increases expression ISO RGD:733718 6480464 propionaldehyde results in increased expression of ANXA6 mRNA CTD PMID:26079696 propiconazole decreases expression ISO RGD:733719 6480464 propiconazole results in decreased expression of ANXA6 mRNA CTD PMID:21278054 pyrethrins decreases expression EXP 6480464 Pyrethrins results in decreased expression of ANXA6 protein CTD PMID:34896426 quercetin decreases expression ISO RGD:733718 6480464 Quercetin results in decreased expression of ANXA6 mRNA CTD PMID:21632981 resveratrol multiple interactions ISO RGD:733718 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of ANXA6 mRNA CTD PMID:23557933 rotenone increases expression EXP 6480464 Rotenone results in increased expression of ANXA6 mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:733718 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA6 mRNA CTD PMID:27188386 silicon dioxide increases expression ISO RGD:733718 6480464 Silicon Dioxide results in increased expression of ANXA6 mRNA CTD PMID:25351596 sodium arsenite multiple interactions ISO RGD:733718 6480464 sodium arsenite promotes the reaction [ANXA6 protein binds to CAPRIN1 protein] CTD PMID:33939924 sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of ANXA6 mRNA CTD PMID:22110744 sodium fluoride decreases expression ISO RGD:733719 6480464 Sodium Fluoride results in decreased expression of ANXA6 mRNA CTD PMID:27862939 sunitinib decreases expression ISO RGD:733718 6480464 Sunitinib results in decreased expression of ANXA6 mRNA CTD PMID:31533062 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of ANXA6 mRNA CTD PMID:31150632 tetrachloromethane increases expression ISO RGD:733719 6480464 Carbon Tetrachloride results in increased expression of ANXA6 mRNA CTD PMID:35483553 tetrachloromethane multiple interactions ISO RGD:733719 6480464 ANXA6 mRNA affects the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] more ... CTD PMID:35483553 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ANXA6 mRNA] CTD PMID:31150632 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of ANXA6 mRNA CTD PMID:34492290 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of ANXA6 mRNA CTD PMID:33387578 tunicamycin decreases expression ISO RGD:733719 6480464 Tunicamycin results in decreased expression of ANXA6 mRNA CTD PMID:17127020 urethane decreases expression ISO RGD:733718 6480464 Urethane results in decreased expression of ANXA6 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:733718 6480464 Valproic Acid affects the expression of ANXA6 mRNA CTD PMID:25979313 valproic acid multiple interactions ISO RGD:733718 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA6 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:733718 6480464 Valproic Acid results in increased expression of ANXA6 mRNA CTD PMID:23179753 more ... vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of ANXA6 mRNA CTD PMID:22570695 vitamin E increases expression ISO RGD:733718 6480464 Vitamin E results in increased expression of ANXA6 mRNA CTD PMID:19244175 vorinostat increases expression ISO RGD:733718 6480464 vorinostat results in increased expression of ANXA6 protein CTD PMID:20543569 vorinostat multiple interactions ISO RGD:733718 6480464 [decitabine co-treated with vorinostat] affects the expression of ANXA6 mRNA CTD PMID:17330099